Exploring the spectrum of incidental gastric polyps in autoimmune gastritis.

[1]  P. Malfertheiner,et al.  Autoimmune gastritis: long-term natural history in naïve Helicobacter pylori-negative patients , 2022, Gut.

[2]  D. Trad,et al.  Gastric polyps: a 10-year analysis of 18,496 upper endoscopies , 2022, BMC Gastroenterology.

[3]  E. Kuipers,et al.  AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review. , 2021, Gastroenterology.

[4]  M. Iwamuro,et al.  Gastric Adenoma: A High Incidence Rate of Developing Carcinoma and Risk of Metachronous Gastric Cancer according to Long-Term Follow-Up , 2021, Digestion.

[5]  Satya N. Das,et al.  Epidemiology, Incidence, and Prevalence of Neuroendocrine Neoplasms: Are There Global Differences? , 2021, Current Oncology Reports.

[6]  Monjur Ahmed.  Gastrointestinal neuroendocrine tumors in 2020 , 2020, World journal of gastrointestinal oncology.

[7]  M. Rugge,et al.  Autoimmune gastritis , 2020, Nature Reviews Disease Primers.

[8]  G. Kim.  Proton Pump Inhibitor-Related Gastric Mucosal Changes , 2020, Gut and liver.

[9]  E. Lahner,et al.  A current clinical overview of atrophic gastritis , 2020, Expert review of gastroenterology & hepatology.

[10]  Peter Schirmacher,et al.  The 2019 WHO classification of tumours of the digestive system , 2019, Histopathology.

[11]  A. Vanoli,et al.  Natural history of autoimmune atrophic gastritis: a prospective, single centre, long‐term experience , 2019, Alimentary pharmacology & therapeutics.

[12]  A. Faggiano,et al.  Tumour type and size are prognostic factors in gastric neuroendocrine neoplasia: A multicentre retrospective study. , 2019, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[13]  F. Prat,et al.  The ENETS TNM staging and grading system accurately predict prognosis in patients with rectal NENs. , 2019, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[14]  P. Invernizzi,et al.  The changing face of chronic autoimmune atrophic gastritis: an updated comprehensive perspective. , 2019, Autoimmunity reviews.

[15]  L. Bin,et al.  The significance of OLGA and OLGIM staging systems in the risk assessment of gastric cancer: a systematic review and meta-analysis , 2018, Gastric Cancer.

[16]  P. Pimentel-Nunes,et al.  Evaluation and management of gastric epithelial polyps. , 2017, Best practice & research. Clinical gastroenterology.

[17]  Mototsugu Kato,et al.  Gastric Hyperplastic Polyps Associated with Proton Pump Inhibitor Use in a Case without a History of Helicobacter pylori Infection , 2017, Internal medicine.

[18]  A. Markowska,et al.  Pathophysiological and clinical aspects of gastric hyperplastic polyps , 2016, World journal of gastroenterology.

[19]  H. Mashima,et al.  Malignant transformation of a gastric hyperplastic polyp in a context of Helicobacter pylori-negative autoimmune gastritis: a case report , 2016, BMC Gastroenterology.

[20]  P. Ruszniewski,et al.  ENETS Consensus Guidelines Update for Gastroduodenal Neuroendocrine Neoplasms , 2016, Neuroendocrinology.

[21]  D. Conte,et al.  Intermittent treatment of recurrent type-1 gastric carcinoids with somatostatin analogues in patients with chronic autoimmune atrophic gastritis. , 2015, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[22]  D. Conte,et al.  Gastric neuroendocrine neoplasms and proton pump inhibitors: fact or coincidence? , 2015, Scandinavian journal of gastroenterology.

[23]  A. Sonnenberg,et al.  Prevalence of benign gastric polyps in a large pathology database. , 2015, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[24]  P. Correa.  Gastric cancer: overview. , 2013, Gastroenterology clinics of North America.

[25]  Bangmao Wang,et al.  Distribution trends of gastric polyps: An endoscopy database analysis of 24 121 northern Chinese patients , 2012, Journal of gastroenterology and hepatology.

[26]  E. Lahner,et al.  Risk for gastric neoplasias in patients with chronic atrophic gastritis: a critical reappraisal. , 2012, World journal of gastroenterology.

[27]  E. Pilozzi,et al.  Development of type I gastric carcinoid in patients with chronic atrophic gastritis , 2011, Alimentary pharmacology & therapeutics.

[28]  H. Brenner,et al.  Incidence of chronic atrophic gastritis: systematic review and meta-analysis of follow-up studies , 2010, European Journal of Epidemiology.

[29]  E. Kuipers,et al.  The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis. , 2010, Gastrointestinal endoscopy.

[30]  G. delle Fave,et al.  Risk factors for progression to gastric neoplastic lesions in patients with atrophic gastritis , 2010, Alimentary pharmacology & therapeutics.

[31]  E. Lahner,et al.  Reassessment of Intrinsic Factor and Parietal Cell Autoantibodies in Atrophic Gastritis With Respect to Cobalamin Deficiency , 2009, The American Journal of Gastroenterology.

[32]  M. Saboorian,et al.  The Current Spectrum of Gastric Polyps: A 1-Year National Study of over 120,000 Patients , 2009, The American Journal of Gastroenterology.

[33]  M. Spampatti,et al.  Gastric carcinoids: between underestimation and overtreatment. , 2009, World journal of gastroenterology.

[34]  D. Graham,et al.  Gastritis staging in clinical practice: the OLGA staging system , 2006, Gut.

[35]  D. Conte,et al.  Plasma chromogranin A in patients with autoimmune chronic atrophic gastritis, enterochromaffin-like cell lesions and gastric carcinoids. , 2005, European journal of endocrinology.

[36]  G. delle Fave,et al.  Atrophic body gastritis patients with enterochromaffin-like cell dysplasia are at increased risk for the development of type I gastric carcinoid , 2001, European journal of gastroenterology & hepatology.

[37]  Vikesh K. Singh,et al.  Hyperplastic Polyps of the Stomach: Associations With Histologic Patterns of Gastritis and Gastric Atrophy , 2001, The American journal of surgical pathology.

[38]  M. Stolte,et al.  Gastric polyps: an update of their pathology and biological significance , 2000, Virchows Archiv.

[39]  C. Bordi,et al.  Atrophic Body Gastritis: Distinct Features Associated with Helicobacter pylori Infection , 1997, Helicobacter.

[40]  M F Dixon,et al.  Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. , 1996, The American journal of surgical pathology.

[41]  L. Villani,et al.  Enterochromaffin-like (ECL) cells and their growths: relationships to gastrin, reduced acid secretion and gastritis. , 1993, Bailliere's clinical gastroenterology.

[42]  A. Oshima,et al.  Fundal atrophic gastritis as a risk factor for gastric cancer , 1993, International journal of cancer.

[43]  P. Cotton,et al.  Development of gastric dysplasia in pernicious anaemia: a clinical and endoscopic follow up study of 80 patients. , 1990, Gut.

[44]  P. Cotton,et al.  Gastroscopic screening in 80 patients with pernicious anaemia. , 1983, Gut.